Clinical Trial: Angiotensin-(1-7) and Energy Expenditure in Human Obesity

U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT03777215) titled 'Angiotensin-(1-7) and Energy Expenditure in Human Obesity' on Dec. 12, 2018.

Brief Summary: The objective of this study is to better define the role of the hormone angiotensin-(1-7) in energy balance. We will test the overall hypothesis that angiotensin-(1-7) increases resting energy expenditure and promotes markers of heat production (thermogenesis) in white adipose tissue in human obesity.

Study Type: Interventional

Condition: Obesity

Intervention: * Drug: Angiotensin-(1-7)

This is a biologically active beneficial hormone of the renin-angiotensin system.

Other Name: Angiotensin I/II (1-7) Acetate

* Drug: Saline

Saline will ...